Mpox Cases Rise in Ceará: Third Confirmed Infection Reported in 2026
Health authorities in the state of Ceará, Brazil, have confirmed a third case of mpox (formerly known as monkeypox) in 2026, according to data released Friday, March 20th. The case, detected through the IntegraSUS monitoring platform, is the latest indication that while the global outbreak appears contained, the virus continues to circulate. This latest confirmation follows two previous cases identified earlier this year, all of which have been reported in the state capital, Fortaleza. The ongoing monitoring and reporting of mpox cases are crucial for public health preparedness and response, particularly as the virus can present with varied symptoms and affect different populations.
As of today, March 20, 2026, Ceará has notified a total of 29 suspected cases of mpox, with 24 ruled out, three confirmed, and two currently under laboratory analysis. This data underscores the importance of continued vigilance and testing to accurately track the spread of the virus and implement appropriate control measures. The Brazilian Ministry of Health continues to monitor the situation nationally, providing guidance and resources to state and local health officials.
Transmission and Symptoms
Mpox is a viral zoonotic disease, meaning it originates in animals but can be transmitted to humans. The primary mode of transmission is through close contact with lesions, body fluids, or contaminated materials. This can include direct contact with skin rashes, scabs, or bodily fluids, as well as contact with items like clothing, bedding, or shared medical equipment that have been contaminated by the virus. The World Health Organization (WHO) notes that while the virus can spread through respiratory secretions, this typically requires prolonged, face-to-face contact. The WHO provides detailed information on mpox transmission and prevention.
Symptoms of mpox typically begin with fever, swollen lymph nodes, and headache, followed by the development of a characteristic rash. This rash often starts on the face and spreads to other parts of the body, progressing through stages of flat spots, raised bumps, fluid-filled blisters, and eventually scabs. The illness can be painful and may require medical attention, particularly for individuals with underlying health conditions or weakened immune systems.
First Case in Ceará Confirmed in March
The first confirmed case of mpox in Ceará in 2026 was reported on March 10th, involving a 37-year-ancient white male with a high school education. According to a report by Diário do Nordeste, the patient received appropriate medical care and experienced a favorable clinical outcome. Details of the first case were initially reported by the local news outlet. Information regarding the second confirmed case has not been publicly released.
Preventive Measures and Public Health Recommendations
The Secretaria da Saúde do Ceará recommends several preventive measures to reduce the risk of mpox transmission. These include avoiding close contact with individuals exhibiting symptoms or confirmed to have the infection, practicing decent hand hygiene with soap and water or alcohol-based hand sanitizer, and wearing a protective mask covering the nose and mouth in situations where risk of exposure is elevated. These recommendations align with guidance from national and international health organizations.
The state health department emphasizes the importance of early detection and reporting of suspected cases. Individuals experiencing symptoms consistent with mpox are urged to seek medical attention promptly. Diagnostic testing involves laboratory analysis of samples collected from skin lesions, utilizing molecular tests or genetic sequencing to confirm the presence of the virus. Samples are sent to reference laboratories in Brazil for analysis, according to the Ministry of Health.
Mpox Trends in Brazil
While the current outbreak appears to be less severe than the initial global surge in 2022, mpox continues to be a public health concern. In 2025, Ceará reported 13 confirmed cases of the disease, while in 2024, the state recorded a total of 24 confirmed cases. Data from G1 indicates a fluctuating pattern of cases over the past three years. The ongoing surveillance efforts are essential for understanding the evolving epidemiology of mpox and tailoring public health interventions accordingly.
The Brazilian Ministry of Health is actively working to procure and distribute vaccines against mpox, prioritizing individuals at higher risk of exposure, including healthcare workers and those with close contact with confirmed cases. Vaccination is considered a key strategy for controlling the spread of the virus and protecting vulnerable populations. However, vaccine availability remains a challenge in some areas.
The recent increase in cases in Ceará serves as a reminder that mpox has not been eradicated and that continued vigilance is necessary. Public health officials are urging residents to stay informed about the virus, practice preventive measures, and seek medical attention if they experience symptoms. The situation is being closely monitored, and further updates will be provided as they become available.
The next official update on mpox cases in Ceará is expected from the Secretaria da Saúde do Ceará on April 3, 2026. Readers are encouraged to share this information with their communities and to consult with healthcare professionals for personalized advice and guidance.
Related reading